Skip to main content
Delfa

← All assets

Aripiprazole

5 trials in this asset. Source: ClinicalTrials.gov, as of July 21, 2026.

Trials

5

Ongoing

0

Recruiting

0

Completed

5

Sites

56

Countries

1

Endpoints

89

Composite endpoints

0

Distinct sites and countries across this asset's trials. A site running several of its trials counts once, matching the map. All 89 linked ClinicalTrials.gov endpoints are classified into the categories below. Trial and endpoint linkage does not by itself establish treatment attribution for every endpoint.

Development

Where the program stands

Trials by phase

Phase 3
4
Phase 4
1

Trials by status

Completed
5

Evidence coverage

What this asset has been measured on

Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.

Behavior / neuropsychiatric
42
Safety / tolerability / PK
20
Other (unclassified)
19
Other clinical outcomes
6
Global cognition
2

Most-measured metrics

Top 20 metrics across this asset's endpoints

Normalized metric codes are available for 42 of 89 classified ClinicalTrials.gov endpoints for this asset; the ranking below covers that coded subset.

Neuropsychiatric Inventory (NPI)Behavior

40

Mini-Mental State Examination (MMSE)Cognition

2

Trials

Trials for this asset

Every trial for this asset, with the same search, filters, and sort as the Trials tab.

5 of 5

Alzheimer’s disease and related dementias trials
Asset / Disease areaKey I/E criterionEvidence
NCT00036114Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Aripiprazole

Alzheimer’s disease

Age 55-95Ph 3Completed41Aug 20031
NCT00095719Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia

Aripiprazole

Alzheimer’s disease

Alzheimer's diseasePh 3Completed14Mar 2005-
NCT00041678Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Aripiprazole

Alzheimer’s disease

Age 55-95Ph 3Completed6Mar 2003-
NCT00245206Side Effects of Newer Antipsychotics in Older Adults

Aripiprazole, Olanzapine, Risperidone

Alzheimer’s disease

Age ≥40Ph 4Completed1Oct 20102
NCT01438060Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type

Aripiprazole

Alzheimer’s disease

Alzheimer's diseasePh 3Completed0Jul 2010-results

Showing 1-5 of 5 trials